Kyrgyzstan vs Turkmenistan: Cases started on MDR-TB treatment
Kyrgyzstan
725
in 2024
Turkmenistan
627
in 2024
Kyrgyzstan rank
25th
Turkmenistan rank
27th
Cases started on MDR-TB treatment over time
- Kyrgyzstan
- Turkmenistan
How they compare
Kyrgyzstan currently reports 725 against 627 in Turkmenistan, a difference of 98.
That makes Kyrgyzstan's figure about 1.2 times Turkmenistan's.
The two have swapped places 2 times across 12 shared years of data; in 2013 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 25th and Turkmenistan ranks 27th of 193 countries.
Kyrgyzstan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,183 | 460.43 | 722.29 | Kyrgyzstan |
| 2020s | 845.2 | 775.8 | 69.4 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Kyrgyzstan or Turkmenistan?
- Kyrgyzstan, at 725 against 627 in Turkmenistan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Kyrgyzstan and Turkmenistan?
- 98, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Turkmenistan?
- 12 years are reported by both, from 2013 to 2024.
- How do Kyrgyzstan and Turkmenistan rank globally for cases started on mdr-tb treatment?
- Kyrgyzstan ranks 25th and Turkmenistan ranks 27th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.